opigolix
Modify Date: 2025-08-26 15:25:30
opigolix structure
|
Common Name | opigolix | ||
|---|---|---|---|---|
| CAS Number | 912587-25-8 | Molecular Weight | 544.502 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 706.9±70.0 °C at 760 mmHg | |
| Molecular Formula | C25H19F3N4O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 381.3±35.7 °C | |
Use of opigolixOpigolix is a Gonadotropin-releasing hormone (GnRH) receptor antagonist, used for the research of endometriosis and rheumatoid arthritis. |
| Name | opigolix |
|---|---|
| Synonym | More Synonyms |
| Description | Opigolix is a Gonadotropin-releasing hormone (GnRH) receptor antagonist, used for the research of endometriosis and rheumatoid arthritis. |
|---|---|
| Related Catalog | |
| Target |
GnRH receptor[1] |
| In Vitro | Opigolix (Compound 726) is a GnRH receptor antagonist, used for the research of sex hormone-dependent diseases, particularly GnRH-related diseases[1]. |
| References |
[1]. Hirano, Masaaki, et al. PROPANE-1,3-DION DERIVATIVE OR SALT THEREOF. WO 2006106812 A1. |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 706.9±70.0 °C at 760 mmHg |
| Molecular Formula | C25H19F3N4O5S |
| Molecular Weight | 544.502 |
| Flash Point | 381.3±35.7 °C |
| Exact Mass | 544.102844 |
| LogP | 0.45 |
| Vapour Pressure | 0.0±2.4 mmHg at 25°C |
| Index of Refraction | 1.665 |
| InChIKey | QLLWADSMMMNRDJ-GFCCVEGCSA-N |
| SMILES | CC(O)C(N)=NS(=O)(=O)c1cc(C(O)=C(C(=O)c2cc(F)ccc2F)c2nc3ccccc3[nH]2)ccc1F |
| VQ6CK0CITA |
| (1Z,2R)-N'-({5-[3-(2,5-Difluorophenyl)-2-(1,3-dihydro-2H-benzimidazol-2-ylidene)-3-oxopropanoyl]-2-fluorophenyl}sulfonyl)-2-hydroxypropanimidamide |
| UNII:VQ6CK0CITA |
| Opigolix |
| Propanimidamide, N'-[[5-[3-(2,5-difluorophenyl)-2-(1,3-dihydro-2H-benzimidazol-2-ylidene)-1,3-dioxopropyl]-2-fluorophenyl]sulfonyl]-2-hydroxy-, (1Z,2R)- |
| UNII-VQ6CK0CITA |